DGAP-Adhoc: Balda AG: Sale of the entire operating business, distributions of EUR 2.00 per share, approval of AGM required


Balda AG / Key word(s): Disposal

23.09.2015 02:38

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted

by DGAP – a service of EQS Group AG.

The issuer is solely responsible for the content of this announcement.


Bad Oeynhausen, 23 September 2015 – Today, Balda AG concluded a purchase

agreement concerning the sales of its entire operating business for a

purchase price of EUR 62.9 million. The buyers are acquiring companies

managed by the investment company Paragon, Munich. The sale comprises all

operational units of the Balda Group, i.e. Balda Medical GmbH & Co. KG, Bad

Oeynhausen, Balda C. Brewer, Inc. and Balda Precision, Inc., both in

California, USA, as well as Balda Medical Systems SRL, Romania and further

assets. The buyer will retain all employees of the operational units and

employees and members of the management of Balda AG. The Balda Group is to

be continued and further extended as operational unit in accordance with

today’s strategic orientation. All in all, the company receives a gross

amount (including profits to be paid out for the past business year) of EUR

approximately 66.7 million (before exemptions, taxes and costs).

The agreement is subject to the condition precedent of approval by the

annual general meeting of Balda AG as well as the approval by the

anti-trust authorities. The Management Board will shortly convene the

annual general meeting scheduled for 19 November 2015. Moreover, the

Management Board and the Supervisory Board intend to suggest a dividend

payment of EUR 1.10 per share. In addition, on approval of the purchase

agreement the Management Board and the Supervisory Board will propose to

reduce the share capital from currently EUR 58,890,636.00 to EUR

5,889,063.00 and return to the shareholders the share capital thus

released. This corresponds to an amount of another EUR 0.90 per current


In this context, the annual general meeting will also adopt a decision

concerning a change of the business purpose of the company and the company


contact / contact person

Michael Pfister

Deekeling Arndt Advisors

Tel: +49 (0) 5734 922 2555

Mobil: +49 (0) 160 90560506

Mail: michael.pfister@deekeling-arndt.de

About Balda

Balda (ISIN: DE0005215107) is a provider of high-end plastics solutions

that rely on quality in sophisticated fields of application in the

healthcare, lifestyle, automotive and consumer electronics industry. Balda

operates in Europe and Northern America and has state of the art production

sites at the Oeynhausen headquarters in Germany and in the US. The

company’s success with its about 780 staff worldwide is based on the use of

modern, cost-efficient technologies and the close cooperation with our

customers in a spirit of trust.


23.09.2015 The DGAP Distribution Services include Regulatory Announcements,

Financial/Corporate News and Press Releases.

Media archive at www.dgap-medientreff.de and www.dgap.de


Language: English

Company: Balda AG

Bergkirchener Str. 228

32549 Bad Oeynhausen


Phone: +49 (0) 57 34 / 9 22-0

Fax: +49 (0) 57 34 / 9 22-2604

E-mail: ir@balda-group.com

Internet: www.balda-group.com

ISIN: DE0005215107

WKN: 521510

Listed: Regulated Market in Frankfurt (Prime Standard); Regulated

Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover,

Munich, Stuttgart

End of Announcement DGAP News-Service